Profund Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $274K | Sell |
8,680
-110
| -1% | -$3.47K | 0.01% | 739 |
|
|
2025
Q1 | $288K | Buy |
8,790
+1,151
| +15% | +$37.7K | 0.01% | 708 |
|
|
2024
Q4 | $276K | Sell |
7,639
-2,947
| -28% | -$107K | 0.01% | 812 |
|
|
2024
Q3 | $330K | Sell |
10,586
-608
| -5% | -$19K | 0.01% | 745 |
|
|
2024
Q2 | $299K | Buy |
11,194
+4,543
| +68% | +$122K | 0.01% | 723 |
|
|
2024
Q1 | $227K | Sell |
6,651
-3,118
| -32% | -$106K | 0.01% | 1012 |
|
|
2023
Q4 | $283K | Buy |
9,769
+109
| +1% | +$3.15K | 0.01% | 814 |
|
|
2023
Q3 | $266K | Buy |
9,660
+1,454
| +18% | +$40.1K | 0.01% | 726 |
|
|
2023
Q2 | $247K | Sell |
8,206
-382
| -4% | -$11.5K | 0.01% | 839 |
|
|
2023
Q1 | $311K | Buy |
+8,588
| New | +$311K | 0.02% | 698 |
|
|
2019
Q1 | – | Sell |
-7,373
| Closed | -$245K | – | 1240 |
|
|
2018
Q4 | $245K | Sell |
7,373
-2,523
| -25% | -$83.8K | 0.02% | 907 |
|
|
2018
Q3 | $498K | Sell |
9,896
-1,414
| -13% | -$71.2K | 0.02% | 819 |
|
|
2018
Q2 | $677K | Buy |
11,310
+1,162
| +11% | +$69.6K | 0.03% | 571 |
|
|
2018
Q1 | $465K | Buy |
10,148
+2,719
| +37% | +$125K | 0.02% | 848 |
|
|
2017
Q4 | $296K | Buy |
7,429
+1,107
| +18% | +$44.1K | 0.01% | 1136 |
|
|
2017
Q3 | $253K | Sell |
6,322
-2,921
| -32% | -$117K | 0.01% | 1215 |
|
|
2017
Q2 | $398K | Buy |
9,243
+526
| +6% | +$22.6K | 0.02% | 900 |
|
|
2017
Q1 | $273K | Sell |
8,717
-986
| -10% | -$30.9K | 0.01% | 1215 |
|
|
2016
Q4 | $245K | Buy |
+9,703
| New | +$245K | 0.01% | 1343 |
|